Beijing Kaixiang Hongkang Biotechnology Co., Ltd.

Overview

Beijing Kaixiang Hongkang Biotechnology Co., Ltd. is a biotechnology company specializing in the development and commercialization of innovative therapies. The company focuses on improving patient outcomes through cutting-edge research and collaborative partnerships.

Therapeutic areas

API / Drug Master Files

Beijing Kaixiang Hongkang Biotechnology Co., Ltd. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• EXOSOMES DERIVED FROM INDUCED PLURIPOTENT STEM CELLSActive2026-03-16

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Beijing Kaixiang Hongkang Biotechnology Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.